Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001192482-20-000435

Options or other derivatives

  • Chief Financial Officer acquired 60,479 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Celano Michael · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +60,479 60,479 D
Loading xslF345X03/edgar.xml…